They’re all artists to Scam Goddess author Laci Mosley ... don’t’: Jenna Ortega is asking TikTokers to stop messing with Wednesday Addams dolls Hims & Hers Health stock tanks after FDA says competitor ...

Hims and Roman doses of sildenafil begin at ... Prescriptions not filled through legitimate channels may not be FDA-approved, may have inaccurate labeling on the packaging, and may have ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...

Telehealth company Hims & Hers Health (HIMS 3.09%) has been great for investors this year by almost any standard; share prices have nearly doubled from a year ago. Yet shareholders aren't feeling ...

Hims & Hers (NYSE:HIMS), the telehealth platform that offers compounded versions of weight loss drugs, dropped more than 10% on Thursday after the FDA confirmed that Eli Lilly's (LLY) GLP-1 ...

Hims & Hers is a fantastic value despite its high 'on-the-surface' P/E ratio and valuation metrics. The company's subscription-based model in healthcare, targeting chronic conditions, ensures ...

As a player in the growing telehealth sector, Hims & Hers Health ($HIMS) has grown significantly, driving its stock up over ...

Advertiser Disclosure. Hims is an online telehealth platform for men that provides care for mental health, sexual health, hair loss, skincare and more. Outside of offering telehealth appointments ...